In those with obesity, however, patients with GLP-1 exposure were significantly less likely to be below gestational weight gain recommendations (adjusted odds ratio [aOR], 0.38
Contact us to schedule an appointment at our Atlanta or Alpharetta office
We would like to hear about peoples experiences of using semaglutide, a drug sold under the brand name of Ozempic for people with type-2 diabetes, and as Wegovy for certain groups of people with obesity
In the pivotal SURPASS clinical trial program evaluating tirzepatide for type 2 diabetes, arthralgia was documented as an adverse event, but occurred at similar rates in both tirzepatide and comparator groups, suggesting it may not be directly attributable to the medication itself
Histology and histopathology , 17 (3), 707714